☰

Thomas A. Mace, Ph.D. - Publications

Affiliations: 
2011 Microbiology and Immunology State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Immunology, Cell Biology
Tree Info Similar researchers PubMed Report error

18/80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ware MB, Phillips M, McQuinn C, Zaidi MY, Knochelmann HM, Greene E, Robinson BS, Herting CJ, Mace TA, Chen Z, Zhang C, Farren MR, Ruggieri AN, Bowers JS, Shakya R, et al. Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell and CXCR3-dependent manner. Jci Insight. PMID 36881480 DOI: 10.1172/jci.insight.155006  0.363
2020 Choueiry F, Torok M, Shakya R, Agrawal K, Deems A, Benner B, Hinton A, Shaffer J, Blaser BW, Noonan AM, Williams TM, Dillhoff M, Conwell DL, Hart PA, Cruz-Monserrate Z, ... ... Mace TA, et al. CD200 promotes immunosuppression in the pancreatic tumor microenvironment. Journal For Immunotherapy of Cancer. 8. PMID 32581043 DOI: 10.1136/Jitc-2019-000189  0.393
2019 Pinette A, McMichael E, Courtney NB, Duggan M, Benner BN, Choueiry F, Yu L, Abood D, Mace TA, Carson WE. An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck. Cancer Immunology, Immunotherapy : Cii. PMID 31338557 DOI: 10.1007/s00262-019-02372-2  0.311
2016 Pitarresi JR, Liu X, Sharma SM, Cuitiño MC, Kladney RD, Mace TA, Donohue S, Nayak SG, Qu C, Lee J, Woelke SA, Trela S, LaPak K, Yu L, McElroy J, et al. Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia. Neoplasia (New York, N.Y.). 18: 541-52. PMID 27659014 DOI: 10.1016/J.Neo.2016.07.006  0.329
2016 Eng JW, Mace TA, Sharma R, Twum DY, Peng P, Gibbs JF, Pitoniak R, Reed CB, Abrams SI, Repasky EA, Hylander BL. Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5. Journal For Immunotherapy of Cancer. 4: 33. PMID 27330806 DOI: 10.1186/S40425-016-0136-Y  0.454
2016 Stiff A, Trikha P, Wesolowski R, Kendra K, Hsu V, Uppati S, McMichael EL, Duggan M, Campbell A, Keller K, Landi I, Zhong Y, Dubovsky J, Howard JH, Yu L, ... ... Mace T, et al. Myeloid-derived suppressor cells express Bruton's tyrosine kinase and can be depleted in tumor bearing hosts by ibrutinib treatment. Cancer Research. PMID 26880800 DOI: 10.1158/0008-5472.Can-15-1490  0.31
2016 Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Mace T, ... ... Mace T, ... ... Mace T, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6  0.401
2015 Lesinski GB, Reville PK, Mace TA, Young GS, Ahn-Jarvis J, Thomas-Ahner J, Vodovotz Y, Ameen Z, Grainger E, Riedl K, Schwartz S, Clinton SK. Consumption of Soy Isoflavone Enriched Bread in Men with Prostate Cancer Is Associated with Reduced Proinflammatory Cytokines and Immunosuppressive Cells. Cancer Prevention Research (Philadelphia, Pa.). 8: 1036-44. PMID 26276751 DOI: 10.1158/1940-6207.Capr-14-0464  0.405
2015 Zynda ER, Grimm MJ, Yuan M, Zhong L, Mace TA, Capitano M, Ostberg JR, Lee KP, Pralle A, Repasky EA. a role for the thermal environment in defining co-stimulation requirements for cd4(+) t cell activation. Cell Cycle (Georgetown, Tex.). 0. PMID 26131730 DOI: 10.1080/15384101.2015.1049782  0.625
2014 Mace TA, King SA, Ameen Z, Elnaggar O, Young G, Riedl KM, Schwartz SJ, Clinton SK, Knobloch TJ, Weghorst CM, Lesinski GB. Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling. Cancer Immunology, Immunotherapy : Cii. 63: 889-900. PMID 24893859 DOI: 10.1007/S00262-014-1564-5  0.388
2014 Mace T, Shakya R, Swanson B, Ludwig T, Elnaggar O, Komar H, Yang J, Young G, Frankel W, Muscarella P, Bekaii-Saab T, Bloomston M, Lesinski G. BMS-911543 inhibits viability of tumor and stromal cells and limits disease progression in genetically engineered mice with pancreatic cancer Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P186  0.327
2013 Mace TA, Ameen Z, Collins A, Wojcik S, Mair M, Young GS, Fuchs JR, Eubank TD, Frankel WL, Bekaii-Saab T, Bloomston M, Lesinski GB. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. Cancer Research. 73: 3007-18. PMID 23514705 DOI: 10.1158/0008-5472.Can-12-4601  0.413
2012 Capitano ML, Nemeth MJ, Mace TA, Salisbury-Ruf C, Segal BH, McCarthy PL, Repasky EA. Elevating body temperature enhances hematopoiesis and neutrophil recovery after total body irradiation in an IL-1-, IL-17-, and G-CSF-dependent manner. Blood. 120: 2600-9. PMID 22806894 DOI: 10.1182/Blood-2012-02-409805  0.667
2012 Lee CT, Zhong L, Mace TA, Repasky EA. Elevation in body temperature to fever range enhances and prolongs subsequent responsiveness of macrophages to endotoxin challenge. Plos One. 7: e30077. PMID 22253887 DOI: 10.1371/Journal.Pone.0030077  0.655
2012 Mace TA, Zhong L, Kokolus KM, Repasky EA. Effector CD8+ T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 28: 9-18. PMID 22235780 DOI: 10.3109/02656736.2011.616182  0.743
2011 Mace TA, Zhong L, Kilpatrick C, Zynda E, Lee CT, Capitano M, Minderman H, Repasky EA. Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia. Journal of Leukocyte Biology. 90: 951-62. PMID 21873456 DOI: 10.1189/Jlb.0511229  0.652
2010 Lee CT, Mace T, Repasky EA. Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer? International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 26: 232-46. PMID 20388021 DOI: 10.3109/02656731003601745  0.64
2006 Mace TA, Yamane N, Cheng J, Hylander BL, Repasky EA. The potential of the tumor microenvironment to influence Apo2L/TRAIL induced apoptosis. Immunological Investigations. 35: 279-96. PMID 16916755 DOI: 10.1080/08820130600745463  0.612
Low-probability matches (unlikely to be authored by this person)
2016 Noonan AM, Farren MR, Geyer SM, Huang Y, Tahiri S, Ahn D, Mikhail S, Ciombor KK, Pant S, Aparo S, Sexton J, Marshall JL, Mace TA, Wu CS, El-Rayes B, et al. Randomized Phase II Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27039845 DOI: 10.1038/mt.2016.66  0.295
2015 Mace T, Shakya R, Pitarresi J, Loftus S, Swanson B, Young G, Zhong X, Zimmers T, Ostrowski M, Ludwig T, Bloomston M, Bekaii-Saab T, Lesinski G. Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P366  0.275
2022 Thomas J, Torok MA, Agrawal K, Pfau T, Vu TT, Lyberger J, Chang H, Castillo AMM, Chen M, Remaily B, Kim K, Xie Z, Dillhoff ME, Kulp SK, Behbehani GK, ... ... Mace TA, et al. The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer. International Journal of Molecular Sciences. 23. PMID 35806069 DOI: 10.3390/ijms23137066  0.264
2014 Monk P, Lam E, Mortazavi A, Kendra K, Lesinski GB, Mace TA, Geyer S, Carson WE, Tahiri S, Bhinder A, Clinton SK, Olencki T. A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 37: 180-6. PMID 24598448 DOI: 10.1097/Cji.0000000000000023  0.264
2015 Martin del Campo SE, Levine KM, Mundy-Bosse BL, Grignol VP, Fairchild ET, Campbell AR, Trikha P, Mace TA, Paul BK, Jaime-Ramirez AC, Markowitz J, Kondadasula SV, Guenterberg KD, McClory S, Karpa VI, et al. The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells. Journal of Immunology (Baltimore, Md. : 1950). 195: 1995-2005. PMID 26238487 DOI: 10.4049/Jimmunol.1400084  0.255
2013 Sborov DW, Nuovo G, Stiff A, Mace T, Lesinski G, Benson DM, Efebera YA, Rosko AE, Pichiorri F, Hofmeister CC. A Phase 1 Trial Of Reolysin Alone In Patients With Refractory Or Relapsed Multiple Myeloma Blood. 122: 3208-3208. DOI: 10.1182/blood.v122.21.3208.3208  0.253
2020 Mukherjee D, Bercz LS, Torok MA, Mace TA. Regulation of Cellular Immunity by Activating Transcription Factor 4. Immunology Letters. PMID 33002512 DOI: 10.1016/j.imlet.2020.09.006  0.252
2013 Mace TA, Bloomston M, Lesinski GB. Pancreatic cancer-associated stellate cells: A viable target for reducing immunosuppression in the tumor microenvironment. Oncoimmunology. 2: e24891. PMID 24073373 DOI: 10.4161/onci.24891  0.24
2018 Stiff A, Trikha P, Mundy-Bosse BL, McMichael EL, Mace TA, Benner B, Kendra K, Campbell A, Gautam S, Abood D, Landi I, Hsu V, Duggan MC, Wesolowski R, Old M, et al. Nitric Oxide Production by Myeloid Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29363526 DOI: 10.1158/1078-0432.Ccr-17-0691  0.236
2014 Yang J, Keenan K, Mace T, Ferren M, Bekaii-Saab T, Fuchs J, Schwartz E, Li C, Pui-Kai Li JL, Lesinski G. Cholangiocarcinoma cells secrete soluble factors that activate Jak/STAT signal transduction and promote MDSC expansion Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P271  0.235
2015 Mace TA, Shakya R, Elnaggar O, Wilson K, Komar HM, Yang J, Pitarresi JR, Young GS, Ostrowski MC, Ludwig T, Bekaii-Saab T, Bloomston M, Lesinski GB. Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer. Oncotarget. PMID 26575024 DOI: 10.18632/Oncotarget.6332  0.234
2019 Mace TA, Ware MB, King SA, Loftus S, Farren MR, McMichael E, Scoville S, Geraghty C, Young G, Carson WE, Clinton SK, Lesinski GB. Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function. Scientific Reports. 9: 5068. PMID 30911044 DOI: 10.1038/S41598-019-41687-Z  0.234
2013 Mace TA, Pitaressi J, Shakya R, Frankel W, Eubank T, Bekaii-Saab T, Bloomston M, Phelps M, Ludwig T, Ostrowski M, Lesinski GB. Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P163  0.23
2020 Ware MB, Zaidi MY, Yang J, Turgeon MK, Krasinskas A, Mace TA, Keenan K, Farren MR, Ruggieri AN, Li Y, Zhang C, Chen Z, Young GS, Elnaggar O, Che Z, et al. Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease. British Journal of Cancer. PMID 32747748 DOI: 10.1038/S41416-020-1018-0  0.219
2020 Wesolowski R, Stiff A, Quiroga D, McQuinn C, Li Z, Nitta H, Savardekar H, Benner B, Ramaswamy B, Lustberg M, Layman RM, Macrae E, Kassem M, Williams N, Sardesai S, ... ... Mace TA, et al. Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer. Bmc Cancer. 20: 445. PMID 32429929 DOI: 10.1186/S12885-020-06949-4  0.218
2023 Mukherjee D, Chakraborty S, Bercz L, D'Alesio L, Wedig J, Torok MA, Pfau T, Lathrop H, Jasani S, Guenther A, McGue J, Adu-Ampratwum D, Fuchs JR, Frankel TL, Pietrzak M, ... ... Mace TA, et al. Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression. Iscience. 26: 107408. PMID 37554459 DOI: 10.1016/j.isci.2023.107408  0.209
2021 Herting CJ, Farren MR, Tong Y, Liu Z, O'Neil B, Bekaii-Saab T, Noonan A, McQuinn C, Mace TA, Shaib W, Wu C, El-Rayes BF, Shahda S, Lesinski GB. A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186. Cancer Immunology, Immunotherapy : Cii. PMID 34160684 DOI: 10.1007/s00262-021-02986-5  0.208
2023 Sun SH, Angell CD, Savardekar H, Sundi D, Abood D, Benner B, DiVincenzo MJ, Duggan M, Choueiry F, Mace T, Trikha P, Lapurga G, Johnson C, Carlson EJ, Chung C, et al. BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 37528320 DOI: 10.1007/s00262-023-03497-1  0.204
2012 Sullivan NJ, Tober KL, Burns EM, Schick JS, Riggenbach JA, Mace TA, Bill MA, Young GS, Oberyszyn TM, Lesinski GB. UV light B-mediated inhibition of skin catalase activity promotes Gr-1+ CD11b+ myeloid cell expansion. The Journal of Investigative Dermatology. 132: 695-702. PMID 22030957 DOI: 10.1038/Jid.2011.329  0.189
2012 Bill MA, Nicholas C, Mace TA, Etter JP, Li C, Schwartz EB, Fuchs JR, Young GS, Lin L, Lin J, He L, Phelps M, Li PK, Lesinski GB. Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines. Plos One. 7: e40724. PMID 22899991 DOI: 10.1371/Journal.Pone.0040724  0.188
2017 Gomez-Chou S, Swidnicka-Siergiejko A, Badi N, Chavez-Tomar M, Lesinski GB, Bekaii-Saab T, Farren MR, Mace TA, Schmidt C, Liu Y, Deng D, Hwang RF, Zhou L, Moore TT, Chatterjee D, et al. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment. Cancer Research. PMID 28249896 DOI: 10.1158/0008-5472.Can-16-1986  0.183
2017 Komar HM, Serpa G, Kerscher C, Schwoegl E, Mace TA, Jin M, Yang MC, Chen CS, Bloomston M, Ostrowski MC, Hart PA, Conwell DL, Lesinski GB. Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo. Scientific Reports. 7: 1787. PMID 28496202 DOI: 10.1038/S41598-017-01973-0  0.182
2023 Vu TT, Kim K, Manna M, Thomas J, Remaily B, Montgomery EJ, Costa T, Granchie L, Xie Z, Guo Y, Chen M, Castillo AMM, Kulp SK, Mo X, Nimmagadda S, ... ... Mace TA, et al. Decoupling FcRn and Tumor Contributions to Elevated Immune Checkpoint Inhibitor Clearance in Cancer Cachexia. Pharmacological Research. 107048. PMID 38145833 DOI: 10.1016/j.phrs.2023.107048  0.18
2019 Park D, Shakya R, Koivisto C, Pitarresi JR, Szabolcs M, Kladney R, Hadjis A, Mace TA, Ludwig T. Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains. Plos One. 14: e0226714. PMID 31877165 DOI: 10.1371/Journal.Pone.0226714  0.177
2023 Guo Y, Remaily BC, Thomas J, Kim K, Kulp SK, Mace TA, Ganesan LP, Owen DH, Coss CC, Phelps MA. Antibody drug clearance: an underexplored marker of outcomes with checkpoint inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37921739 DOI: 10.1158/1078-0432.CCR-23-1683  0.162
2018 Pitarresi JR, Liu X, Avendano A, Thies KA, Sizemore GM, Hammer AM, Hildreth BE, Wang DJ, Steck SA, Donohue S, Cuitiño MC, Kladney RD, Mace TA, Chang JJ, Ennis CS, et al. Disruption of stromal hedgehog signaling initiates RNF5-mediated proteasomal degradation of PTEN and accelerates pancreatic tumor growth. Life Science Alliance. 1: e201800190. PMID 30456390 DOI: 10.26508/lsa.201800190  0.161
2021 Castillo AMM, Vu TT, Liva SG, Chen M, Xie Z, Thomas J, Remaily B, Guo Y, Subrayan UL, Costa T, Helms TH, Irby DJ, Kim K, Owen DH, Kulp SK, ... Mace TA, et al. Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans. Jcsm Rapid Communications. 4: 232-244. PMID 34514376 DOI: 10.1002/rco2.32  0.153
2022 Kaur T, Weadick B, Mace TA, Desai K, Odom H, Govindarajan R. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities. Pharmacology & Therapeutics. 108300. PMID 36283452 DOI: 10.1016/j.pharmthera.2022.108300  0.152
2022 Guo Y, Wei L, Patel SH, Lopez G, Grogan M, Li M, Haddad T, Johns A, Ganesan LP, Yang Y, Spakowicz DJ, Shields PG, He K, Bertino EM, Otterson GA, ... ... Mace TA, et al. Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy. Clinical Lung Cancer. PMID 35131184 DOI: 10.1016/j.cllc.2021.12.010  0.152
2013 Mace TA, Collins AL, Wojcik SE, Croce CM, Lesinski GB, Bloomston M. Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. The Journal of Surgical Research. 184: 855-60. PMID 23726431 DOI: 10.1016/J.Jss.2013.04.061  0.152
2018 Ramsey ML, Talbert E, Ahn D, Bekaii-Saab T, Badi N, Bloomston PM, Conwell DL, Cruz-Monserrate Z, Dillhoff M, Farren MR, Hinton A, Krishna SG, Lesinski GB, Mace T, Manilchuk A, et al. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. PMID 30497874 DOI: 10.1016/J.Pan.2018.11.002  0.151
2016 Talbert EE, Yang J, Mace TA, Farren MR, Farris AB, Young GS, Elnaggar O, Che Z, Timmers CD, Rajasekera P, Maskarinec JM, Bloomston M, Bekaii-Saab T, Guttridge DC, Lesinski GB. Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through Both Tumor Extrinsic and Intrinsic Activities. Molecular Cancer Therapeutics. PMID 27811010 DOI: 10.1158/1535-7163.MCT-16-0337  0.145
2016 Mace TA, Shakya R, Pitarresi JR, Swanson B, McQuinn CW, Loftus S, Nordquist E, Cruz-Monserrate Z, Yu L, Young G, Zhong X, Zimmers TA, Ostrowski MC, Ludwig T, Bloomston M, et al. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Gut. PMID 27797936 DOI: 10.1136/Gutjnl-2016-311585  0.134
2015 Farren MR, Mace T, Geyer S, Mikhail S, Wu C, Ciombor KK, Tahiri S, Ahn D, Noonan AM, Villalona-Calero MA, Bekaii-Saab T, Lesinski GB. Systemic immune activity predicts overall survival in treatment naïve patients with metastatic pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26719427 DOI: 10.1158/1078-0432.CCR-15-1732  0.134
2015 Farren MR, Shakya R, Hennessey R, Mace T, Yang J, Elnaggar O, Young G, Landesman Y, Carlson R, Elloul S, Crochiere M, Burd C, Lesinski G. Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P355  0.133
2017 Wesolowski R, Duggan MC, Stiff A, Markowitz J, Trikha P, Levine KM, Schoenfield L, Abdel-Rasoul M, Layman R, Ramaswamy B, Macrae ER, Lustberg MB, Reinbolt RE, Mrozek E, Byrd JC, ... ... Mace TA, et al. Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer. Cancer Immunology, Immunotherapy : Cii. PMID 28688082 DOI: 10.1007/S00262-017-2038-3  0.132
2022 Issa M, Tang J, Guo Y, Coss C, Mace TA, Bischof J, Phelps M, Presley CJ, Owen DH. Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancer. Expert Review of Anticancer Therapy. 1-14. PMID 35786142 DOI: 10.1080/14737140.2022.2094772  0.132
2020 Mukherjee D, DiVincenzo MJ, Torok M, Choueiry F, Kumar RJ, Deems A, Miller JL, Hinton A, Geraghty C, Maranon JA, Kulp SK, Coss C, Carson WE, Conwell DL, Hart PA, ... ... Mace TA, et al. Soy-tomato enriched diet reduces inflammation and disease severity in a pre-clinical model of chronic pancreatitis. Scientific Reports. 10: 21824. PMID 33311549 DOI: 10.1038/s41598-020-78762-9  0.131
2014 Sborov DW, Nuovo GJ, Stiff A, Mace T, Lesinski GB, Benson DM, Efebera YA, Rosko AE, Pichiorri F, Grever MR, Hofmeister CC. A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5946-55. PMID 25294913 DOI: 10.1158/1078-0432.CCR-14-1404  0.118
2015 Farren MR, Mace T, Geyer S, Mikhail S, Wu C, Ciombor K, Tahiri S, Ahn D, Noonan A, Villalona-Calero M, Bekaii-Saab T, Lesinski G. Immunological predictors of overall survival in treatment naïve metastatic pancreatic cancer patients Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P85  0.116
2019 Benner B, Scarberry L, Suarez-Kelly LP, Duggan MC, Campbell AR, Smith E, Lapurga G, Jiang K, Butchar JP, Tridandapani S, Howard JH, Baiocchi RA, Mace TA, Carson WE. Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro. Journal For Immunotherapy of Cancer. 7: 140. PMID 31138333 DOI: 10.1186/S40425-019-0622-0  0.114
2018 Henderson SE, Makhijani N, Mace TA. Pancreatic Cancer-Induced Cachexia and Relevant Mouse Models. Pancreas. 47: 937-945. PMID 30113428 DOI: 10.1097/MPA.0000000000001124  0.112
2020 Gumpper K, Dangel AW, Pita-Grisanti V, Krishna SG, Lara LF, Mace T, Papachristou GI, Conwell DL, Hart PA, Cruz-Monserrate Z. Lipocalin-2 expression and function in pancreatic diseases. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. PMID 31932215 DOI: 10.1016/j.pan.2020.01.002  0.088
2019 Maximenko N, Corradi P, Law KL, Van Sebille E, Garaba SP, Lampitt RS, Galgani F, Martinez-Vicente V, Goddijn-Murphy L, Veiga JM, Thompson RC, Maes C, Moller D, Löscher CR, Addamo AM, ... ... Mace T, et al. Toward the Integrated Marine Debris Observing System Frontiers in Marine Science. 6. DOI: 10.3389/Fmars.2019.00447  0.076
2024 Gumpper-Fedus K, Chasser K, Pita-Grisanti V, Torok M, Pfau T, Mace TA, Cole RM, Belury MA, Culp S, Hart PA, Krishna SG, Lara LF, Ramsey ML, Fisher W, Fogel EL, et al. Systemic Neutrophil Gelatinase-Associated Lipocalin Alterations in Chronic Pancreatitis: A Multicenter, Cross-Sectional Study. Clinical and Translational Gastroenterology. PMID 38284831 DOI: 10.14309/ctg.0000000000000686  0.073
2013 McGettigan P, McKendree J, Reed N, Holborow S, Walsh CD, Mace T. Identifying attributes required by Foundation Year 1 doctors in multidisciplinary teams: a tool for performance evaluation. Bmj Quality & Safety. 22: 225-32. PMID 23362506 DOI: 10.1136/Bmjqs-2012-001418  0.067
2014 Gutierrez-Orozco F, Thomas-Ahner JM, Berman-Booty LD, Galley JD, Chitchumroonchokchai C, Mace T, Suksamrarn S, Bailey MT, Clinton SK, Lesinski GB, Failla ML. Dietary α-mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in mice. Molecular Nutrition & Food Research. 58: 1226-38. PMID 24668769 DOI: 10.1002/Mnfr.201300771  0.067
2020 Sundi* D, Duggan M, Savardekar H, Sun S, Kwon H, Brown J, Zhao J, Mace T, Carson W. PD47-03 PRE-CLINCICAL CELLULAR AND GENOMIC BIOMARKERS OF RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE IN UROTHELIAL CARCINOMA The Journal of Urology. 203: e926. DOI: 10.1097/ju.0000000000000934.03  0.067
2021 Cruz-Monserrate Z, Gumpper K, Kaul S, Badi N, Terhorst S, Dubay K, Lesinski GB, Fisher W, McElhany A, Lara LF, Krishna S, Mace T, Higuita-Castro N, Ortega-Pineda L, Freitas MA, et al. Delayed Processing of Secretin-Induced Pancreas Fluid Influences the Quality and Integrity of Proteins and Nucleic Acids. Pancreas. 50: 17-28. PMID 33370019 DOI: 10.1097/MPA.0000000000001717  0.064
2018 Fisher WE, Cruz-Monserrate Z, McElhany AL, Lesinski GB, Hart PA, Ghosh R, Van Buren G, Fishman DS, Rinaudo JAS, Serrano J, Srivastava S, Mace T, Topazian M, Feng Z, Yadav D, et al. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas. 47: 1213-1221. PMID 30325860 DOI: 10.1097/Mpa.0000000000001171  0.064
2023 Pita-Grisanti V, Dubay K, Lahooti A, Badi N, Ueltschi O, Gumpper-Fedus K, Hsueh HY, Lahooti I, Chavez-Tomar M, Terhorst S, Knoblaugh SE, Cao L, Huang W, Coss CC, Mace TA, et al. Physical Activity Delays Obesity-Associated Pancreatic Ductal Adenocarcinoma in Mice and Decreases Inflammation. Biorxiv : the Preprint Server For Biology. PMID 36711764 DOI: 10.1101/2023.01.03.521203  0.064
2022 Han S, Conwell DL, Li L, Cervantes A, Hart PA, Cruz-Monserrate Z, Hao W, Lesinski GB, Mace T, Palermo TM, Saloman JL, Yadav D, Vege SS, Topazian M. The phase 1/2 trial of indomethacin in chronic pancreatitis (The PAIR trial): Protocol for a parallel multi-center randomized controlled trial. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. PMID 36535851 DOI: 10.1016/j.pan.2022.12.008  0.064
2020 Ahn-Jarvis J, Lombardo E, Cruz-Monserrate Z, Badi N, Crowe O, Kaul S, Komar H, Krishna SG, Lesinski GB, Mace TA, Ramsey ML, Roberts K, Stinehart K, Traczek M, Conwell DL, et al. Reduction of inflammation in chronic pancreatitis using a soy bread intervention: A feasibility study. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. PMID 32595109 DOI: 10.1016/J.Pan.2020.04.018  0.055
2014 Rosenzweig C, Horton RM, Bader DA, Brown ME, DeYoung R, Dominguez O, Fellows M, Friedl L, Graham W, Hall C, Higuchi S, Iraci L, Jedlovec G, Kaye J, Loewenstein M, ... Mace T, et al. Enhancing climate resilience at nasa centers: A collaboration between science and stewardship Bulletin of the American Meteorological Society. 95: 1351-1363. DOI: 10.1175/Bams-D-12-00169.1  0.05
1985 De Lorenzi A, Gaio E, Mace TA, Maschio A, Piovan R. POWER SUPPLY PROTECTION AGAINST PLASMA DISRUPTION AND FAULT CONDITIONS IN THE RFX EXPERIMENT . 190-193.  0.043
2014 Bekaii-Saab T, Noonan A, Lesinski G, Mikhail S, Ciombor K, Pant S, Aparo S, Tahiri S, Thompson A, Sexton J, Marshall J, Mace T, Wu C, El-Rayes B, Timmers C, et al. A Multi-Institutional Randomized Phase 2 Trial of the Oncolytic Virus Reolysin in the First Line Treatment Metastatic Adenocarcinoma of the Pancreas (Map) Annals of Oncology. 25: v1. DOI: 10.1093/ANNONC/MDU438.19  0.042
2022 McNabb-Baltar J, Manickavasagan HR, Conwell DL, Lu A, Yadav D, Hart PA, Lara LF, Cruz-Monserrate Z, Ing S, Hinton A, Mace TA, Bradley D, Shah ZK. A Pilot Study to Assess Opportunistic Use of CT-Scan for Osteoporosis Screening in Chronic Pancreatitis. Frontiers in Physiology. 13: 866945. PMID 35721529 DOI: 10.3389/fphys.2022.866945  0.038
1984 Harding GH, Hush M, Jarnot A, Jukes JD, Mitchell NA, Mace TA, Robertson IL, Strachan IG, Thompson VK. COMPUTATIONAL ANALYSIS FOR THE COMPASS MACHINE . 1: 795-801.  0.033
1988 Mace TA, Gray JW, McLachlan RC, Dobson I. Connie - a general ac-dc converter and transient circuit analysis program Ieee Conference Record of Power Modulator Symposium. 109-116.  0.032
2018 Elsworth DW, Mace T. Investigation of Burgage Plots to the Rear of Number 9 High Street and the Town Hall, Off Jerry Croft, Skipton, North Yorkshire Yorkshire Archaeological Journal. 90: 67-95. DOI: 10.1080/00844276.2018.1458442  0.024
2013 Mace TA, Syed A, Bhandari S. Iron (III) isomaltoside 1000. Expert Review of Hematology. 6: 239-46. PMID 23782077 DOI: 10.1586/ehm.13.15  0.01
1984 Rostagni G, Benfatto I, Browning JL, Brunello F, De Lorenzi A, Fellin L, Gnesotto F, Gray JW, Guarnieri M, Mace TA, Majorana CE, Martone R, Maschio A, Modena C, Paolucci A. RFX PROJECT: A DESIGN REVIEW. . 1: 189-201.  0.01
Hide low-probability matches.